• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BD CARIBE LTD. BD MICROTAINER® PST¿ TUBES WITH LH (LITHIUM HEPARIN); TUBES, VIALS, SYSTEMS, SERUM SEPARATORS, BLOOD COLLECTION

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BD CARIBE LTD. BD MICROTAINER® PST¿ TUBES WITH LH (LITHIUM HEPARIN); TUBES, VIALS, SYSTEMS, SERUM SEPARATORS, BLOOD COLLECTION Back to Search Results
Catalog Number 365985
Medical Device Problem Code Incorrect, Inadequate or Imprecise Result or Readings (1535)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 11/15/2024
Type of Reportable Event Malfunction
Additional Manufacturer Narrative
E1: initial reporter facility name: (b)(6) hospital.A device evaluation and/or device history review is anticipated but is not complete.Upon completion, a supplemental report will be filed.
 
Event or Problem Description
It was reported prior to use of bd microtainer® pst¿ tubes with lh (lithium heparin), the additive was stuck to the top in an unspecified number tubes.There was no health impact or consequences reported.
 
Additional Manufacturer Narrative
The following fields were updated due to additional information: d9: device available for evaluation: yes.H.3 device eval by manufacturer? yes.D9: returned to manufacturer on: 24-dec-2024.Investigation summary: bd received a sample and two (2) photos for investigation.The sample and photos were reviewed and the indicated failure mode for gel smearing was observed.Additionally, fifty (50) retention samples from bd inventory, were evaluated by visual examination and the issue of gel smearing was not observed.Complaints for sample quality are under statistical control for the month of november 2024.At this time, further testing is not indicated.The batch history review was satisfactory per internal procedures.This complaint has been confirmed for the indicated failure mode of gel smearing.Bd was not able to identify a root cause for the indicated failure mode.Complaints received for this device and reported condition will continue to be tracked and trended.Our business team regularly reviews the collected data for identification of emerging trends.Bd quality will continue to monitor sample quality complaints.
 
Event or Problem Description
It was reported prior to use of bd microtainer® pst¿ tubes with lh (lithium heparin), the additive was stuck to the top in an unspecified number tubes.There was no health impact or consequences reported.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
BD MICROTAINER® PST¿ TUBES WITH LH (LITHIUM HEPARIN)
Common Device Name
TUBES, VIALS, SYSTEMS, SERUM SEPARATORS, BLOOD COLLECTION
Manufacturer (Section D)
BD CARIBE LTD.
road 31
k.m. 24.3
juncos PR
Manufacturer (Section G)
BD CARIBE LTD.
road 31
k.m. 24.3
juncos PR
Manufacturer Contact
matt j. connor
7 loveton circle
sparks, MD 21152
4103164000
MDR Report Key20871299
Report Number2618282-2024-00182
Device Sequence Number20973599
Product Code JKA
UDI-Device Identifier30382903659853
UDI-Public(01)30382903659853(11)240321(17)250630(10)408133N
Combination Product (Y/N)N
Initial Reporter CountryJA
PMA/510(K) Number
K991702
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)N
Reporter Type Manufacturer
Report Source Company Representative
Initial Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date (Section B) 01/08/2025
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Other
Device Expiration Date06/30/2025
Device Catalogue Number365985
Device Lot Number408133N
Was Device Available for Evaluation? Device Returned to Manufacturer
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 11/15/2024
Supplement Date Received by Manufacturer02/05/2025
Initial Report FDA Received Date12/06/2024
Supplement Report FDA Received Date02/07/2025
Was Device Evaluated by Manufacturer? (Y/N) Yes
Date Device Manufactured03/21/2024
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Patient SexUnknown
-
-